Abstract
Inflammatory Bowel Disease (IBD), a chronic autoimmune disorder triggered by persistent inflammation in the gastrointestinal tract, has been reported to have increased geographically. While current therapies for this disease aim to treat and reduce inflammation, other factors are at play, contributing to the incidence and prevalence rates. Emerging research suggests that the microbiome plays a pivotal role in modulating immune responses, but due to factors such as modern diet, aging, chronic stress, dysfunctional immune system, and inflammation, there has been a reduction in microbiome diversity and immunity, projecting the need for novel approaches in boosting the overall condition of the microbiome environment and immunity. This literature review highlights the possible factors contributing to the prevalence of IBD and explores the immunotherapeutic effects of the strain MYb11, a natural microbiota isolated from the model C. elegans, as a potential probiotic in controlling immune responses, oxidative stress, and inflammation.
Advisor
Strand, Stephanie
Department
Biology
Recommended Citation
Darbah, Carmen Angel, "Exploring the Immunotherapeutic Effects of MYb11 in Modulating Inflammatory Responses" (2025). Senior Independent Study Theses. Paper 11251.
https://openworks.wooster.edu/independentstudy/11251
Disciplines
Medicine and Health Sciences | Public Health
Publication Date
2025
Degree Granted
Bachelor of Arts
Document Type
Senior Independent Study Thesis
© Copyright 2025 Carmen Angel Darbah
